Growth Metrics

Uranium Royalty (UROY) EBITDA (2022 - 2025)

Historic EBITDA for Uranium Royalty (UROY) over the last 4 years, with Q4 2025 value amounting to $3.0 million.

  • Uranium Royalty's EBITDA rose 122562.87% to $3.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $4.0 million, marking a year-over-year decrease of 337.01%. This contributed to the annual value of -$3.4 million for FY2025, which is 16470.66% down from last year.
  • Latest data reveals that Uranium Royalty reported EBITDA of $3.0 million as of Q4 2025, which was up 122562.87% from $1.5 million recorded in Q3 2025.
  • In the past 5 years, Uranium Royalty's EBITDA registered a high of $8.7 million during Q4 2023, and its lowest value of -$5.4 million during Q3 2022.
  • Moreover, its 4-year median value for EBITDA was $1.3 million (2023), whereas its average is $1.2 million.
  • As far as peak fluctuations go, Uranium Royalty's EBITDA tumbled by 26421.33% in 2024, and later surged by 122562.87% in 2025.
  • Uranium Royalty's EBITDA (Quarter) stood at $3.1 million in 2022, then skyrocketed by 176.89% to $8.7 million in 2023, then plummeted by 103.11% to -$269482.3 in 2024, then surged by 1225.63% to $3.0 million in 2025.
  • Its EBITDA was $3.0 million in Q4 2025, compared to $1.5 million in Q3 2025 and $465206.4 in Q2 2025.